Acute tuberculous pericarditis is an uncommon condition. Despite advances in the treatment of tuberculosis, the effect of chemotherapy on its outcome has not been studied fully. In this paper we review, retrospectively, experience in Birmingham.
Patients and methods
The records of all patients who attended the Birmingham Chest Clinic between 1960 and 1976 for tuberculous pericarditis were analysed. They satisfied one or more of the following criteria: (1) histologically proven tuberculous pericarditis; (2) isolation of Mycobacterium tuberculosis from the pericardial fluid; (3) pericarditis with proven extrapericardial tuberculosis; and (4) Follow-up was from one to 16 years (Table 2 ). Nineteen out of 30 (63%) patients treated medically had been followed-up for at least three years and these included nine who had been seen for more than five years. None showed evidence of developing constrictive pericarditis. The six patients who survived pericardiectomy had been followed up for 3-14 years. No recurrence of constriction was found. There were five deaths. One patient was given corticosteroids only for three months for pericardial effusion before the correct diagnosis was made and antituberculosis treatment started. Another died the day after admission. There was one early postpericardiectomy death secondary to ventricular rupture. Two deaths were due to unrelated causes-myocardial infarction and carcinoma.
Discussion
As with other series (Bauer et al., 1956; Hagerman et al., 1964; Roone et al., 1970) acute tuberculous pericarditis was found to be predominantly a disease of adult males. Most of our patients (80%) were Asian. This reflects the higher prevalence of tuberculosis among them. Of note is the absence of Negro patients in our series whereas they form the majority in the papers from North America mentioned above.
Without treatment tuberculous pericarditis results in death or constrictive pericarditis (Andrews et al., 1948; Harvey and Whitehill, 1937) . Streptomycin alone reduced mortality from 90% to 43% (Shapiro and Weiss, 1953) . In our series, the overall mortality was 7%, and in proven cases 18%. This marked improvement is probably due to more effective chemotherapy.
It is probable that the risk of developing constrictive pericarditis is reduced by adequate treatment. This complication occurred in 17% of our patients. Owing to the high mortality in untreated cases it is difficult to be certain about the effect of chemotherapy on the occurrence of this complication, but 16 out of 18 untreated patients reported by Andrews et al. (1948) developed constrictive pericarditis. The finding of tubercle bacilli in the pericardial fluid or caseating granulomata in the pericardium increased the likelihood that constrictive pericarditis would develop. When it occurred, it did so early in the course of the illness. More than half our patients have been followed up for three years or more, and none has shown any evidence of constrictive pericarditis later than six months. Surgery under the cover of adequate chemotherapy is not contraindicated early in the course of the disease since dissemination of tuberculosis or failure of wound healing did not occur.
Four out of seven patients who required pericardiectomy had been given corticosteroids in the acute stage of their illness whereas the other three had only chemotherapy. It is not possible, therefore, to determine the role of corticosteroids in preventing the development of constrictive pericarditis. General improvement occurred more rapidly when corticosteroids were used, and there was no evidence of added risks provided adequate chemotherapy was given concurrently.
Constrictive pericarditis without a previous acute episode was found in a separate series of 15 patients (10 men and 5 women). All were European and their average age was 49 years. None gave a past history of tuberculosis in any site. Pericardiectomy was carried out in 10 patients, and none had histological evidence of tuberculosis.
